Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 5/20 | 0.81 |
| ▸ | RAB9A | P51151 | 5/20 | 0.81 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.81 |
| ▸ | GSK3B | P49841 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | CES2 | O00748 | 1/20 | 0.52 |
| ▸ | CES1 | P23141 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | SRD5A2 | P31213 | 3/20 | 0.50 |
| ▸ | CTBP2 | P56545 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19934276 | 0.92 | NPC1 (0.71) | NPC1RAB9AL3MBTL1GSK3BKMT2A | |
| SCHEMBL12137308 | 0.92 | NPC1 (0.71) | NPC1RAB9AL3MBTL1GSK3BKMT2A | |
| SCHEMBL12637601 | 0.92 | NPC1 (0.71) | NPC1RAB9AL3MBTL1GSK3BKMT2A | |
| SCHEMBL28629860 | 0.92 | NPC1 (0.71) | NPC1RAB9AL3MBTL1GSK3BKMT2A | |
| SCHEMBL6224695 | 0.90 | RAB9A (1.00) | NPC1RAB9AL3MBTL1GSK3BKMT2A | |
| SCHEMBL29756305 | 0.90 | NPC1 (0.69) | NPC1RAB9AL3MBTL1GSK3BKMT2A | |
| SCHEMBL4464874 | 0.90 | NPC1 (0.69) | NPC1RAB9AL3MBTL1GSK3BKMT2A | |
| SCHEMBL6199337 | 0.90 | RAB9A (1.00) | NPC1RAB9AL3MBTL1GSK3BKMT2A | |
| SCHEMBL31151831 | 0.90 | NPC1 (0.69) | NPC1RAB9AL3MBTL1GSK3BKMT2A | |
| SCHEMBL20017608 | 0.90 | NPC1 (0.69) | NPC1RAB9AL3MBTL1GSK3BKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113755862-B | Method for preparing aromatic alpha-diketone compound by electrochemical oxidation | 西南大学 | 2022-08-19 | — | — | CN | claimed |
| CN-113755862-A | Method for preparing aromatic alpha-diketone compound by electrochemical oxidation | 西南大学 | 2021-12-07 | — | — | CN | claimed |
| CN-118791344-A | Method for synthesizing 1, 2-diaryl ketone by alcohol dehydroxycarbonylation | 中国科学院大连化学物理研究所 | 2024-10-18 | — | — | CN | disclosed |
| US-11732138-B2 | Deep ultraviolet-excitable water-solvated polymeric dyes | BECTON, DICKINSON AND COMPANY (US) | 2023-08-22 | — | — | US | disclosed |
| US-20230130025-A1 | PHOTORESIST COMPOSITIONS AND METHODS FOR FABRICATING SEMICONDUCTOR DEVICE USING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2023-04-27 | — | — | US | disclosed |
| CN-113755862-B | Method for preparing aromatic alpha-diketone compound by electrochemical oxidation | 西南大学 | 2022-08-19 | — | — | CN | disclosed |
| CN-113755862-A | Method for preparing aromatic alpha-diketone compound by electrochemical oxidation | 西南大学 | 2021-12-07 | — | — | CN | disclosed |
| US-20180194899-A1 | PRECURSOR FOR POLYIMIDE AND USE THEREOF | ETERNAL MATERIALS CO., LTD. (TW) | 2018-07-12 | — | — | US | disclosed |
| US-20180148544-A1 | PRECURSOR FOR POLYIMIDE AND USE THEREOF | ETERNAL MATERIAL CO., LTD. (TW) | 2018-05-31 | — | — | US | disclosed |
| US-20180148541-A1 | POLYIMIDE PRECURSOR COMPOSITION AND USE THEREOF | ETERNAL MATERIALS CO., LTD. (TW) | 2018-05-31 | — | — | US | disclosed |
| US-20180079962-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND MANUFACTURING METHOD THEREOF | MAGNOLIA PURPLE CORPORATION (JP) | 2018-03-22 | — | — | US | disclosed |
| US-20110054050-A1 | ION EXCHANGE MEMBRANE HAVING LAMELLAR MORPHOLOGY AND PROCESS OF MAKING THE SAME | GM GLOBAL TECHNOLOGY OPERATIONS, INC. (US) | 2011-03-03 | — | — | US | disclosed |
| US-7888433-B2 | Sulfonated-polyperfluoro-cyclobutane-polyphenylene polymers for PEM fuel cell applications | GM GLOBAL TECHNOLOGY OPERATIONS, INC. (US) | 2011-02-15 | — | — | US | disclosed |
| US-20110009506-A1 | PREPARATION METHOD OF POLYBENZOXAZOLES BY THERMAL REARRANGEMENT, POLYBENZOXAZOLES PREPARED THEREBY, AND GAS SEPARATION MEMBRANE COMPRISING THE SAME | INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY (KR) | 2011-01-13 | — | — | US | disclosed |
| WO-2009123969-A2 | DEOXYBENZOIN-DERIVED ANTI-FLAMMABLE POLYMERS | UNIVERSITY OF MASSACHUSETTS (US) | 2009-10-08 | — | — | WO | disclosed |
| US-20090053430-A1 | Liquid Crystal Display Device and Manufacturing Method Thereof | HITACHI DISPLAYS. LTD. | 2009-02-26 | — | — | US | disclosed |
| US-7205302-B2 | Anticoagulants; antilipemic agents; cardiovascular disorders | NIPPON SHINYAKU CO., LTD. (JP) | 2007-04-17 | — | — | US | disclosed |
| EP-1400518-B1 | HETEROCYCLIC COMPOUND DERIVATIVES AND MEDICINES | NIPPON SHINYAKU CO LTD (JP) | 2007-01-17 | — | — | EP | disclosed |
| US-20040102436-A1 | Heterocyclic compound derivatives and medicines | NIPPON SHINYAKU CO., LTD. (JP) | 2004-05-27 | — | — | US | disclosed |
| EP-1400518-A1 | HETEROCYCLIC COMPOUND DERIVATIVES AND MEDICINES | Nippon Shinyaku Co., Ltd. (JP) | 2004-03-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040102436-A1 | Heterocyclic compound derivatives and medicines | CNR2, CNR1, GPR55 | NPC1 1164/4885RAB9A 2545/4885L3MBTL1 4881/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.